Labcorp achieves ivdr ce-marking for pgdx elio™ tissue complete in the eu

First-and-only test of its kind approved under new european union regulations expands access to personalized cancer care for patients across the eu burlington, n.c. , july 29, 2025 /prnewswire/ -- labcorp (nyse: lh), a global leader of innovative and comprehensive laboratory services, announced today pgdx elio™ tissue complete has been ce-marked under the european union's (eu) new in vitro diagnostic regulation (ivdr).
LH Ratings Summary
LH Quant Ranking